This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Oxygen Biotherapeutics Announces FY2011 Year-End And Fourth Quarter Financial Results Conference Call And Webcast

Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) (SWX:OXBT) today announced that the Company plans to report its year-end and fourth quarter fiscal year 2011 financial results on Form 10-K on Thursday, July 14, 2011. Oxygen’s Chairman and CEO Chris Stern and Chief Financial Officer Michael Jebsen will host a conference call and live webcast to discuss the results on Friday, July 15, 2011, at 11 a.m. EDT.

To access the live teleconference dial (800) 688-0836 (U.S. and Canada) or (617) 614-4072 (international). The participant pass code is 26134845. A live webcast will be available on our web site http://www.oxybiomed.com/investors.htm

A replay of the webcast will be available on the Oxygen website, or by phone for a limited time. To access the replay by phone, call (888) 286-8010 (U.S. and Canada) or (617) 801-6888 (international). The pass code for the replay is 98577075.

About Oxygen Biotherapeutics, Inc.

Oxygen Biotherapeutics, Inc. is developing intravenous and topical medical products that deliver oxygen to tissues in the body. Currently, the company is focused on traumatic brain injury, wound healing, dermatologic indications and decompression sickness. In addition, the Company markets and sells its DERMACYTE ® line of oxygen-rich skin care products.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs